PT826375E - Utilizacao de lipidos complexos como aditivos estabilizadores para preparacoes farmaceuticas de misturas de enzimas digestivas - Google Patents

Utilizacao de lipidos complexos como aditivos estabilizadores para preparacoes farmaceuticas de misturas de enzimas digestivas

Info

Publication number
PT826375E
PT826375E PT97114330T PT97114330T PT826375E PT 826375 E PT826375 E PT 826375E PT 97114330 T PT97114330 T PT 97114330T PT 97114330 T PT97114330 T PT 97114330T PT 826375 E PT826375 E PT 826375E
Authority
PT
Portugal
Prior art keywords
pharmaceutical preparations
digestive enzyme
stabilizing additives
enzyme mixtures
complex lipids
Prior art date
Application number
PT97114330T
Other languages
English (en)
Inventor
Galle Manfred
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of PT826375E publication Critical patent/PT826375E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
PT97114330T 1996-08-28 1997-08-20 Utilizacao de lipidos complexos como aditivos estabilizadores para preparacoes farmaceuticas de misturas de enzimas digestivas PT826375E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19634752 1996-08-28
DE19724845A DE19724845A1 (de) 1996-08-28 1997-06-12 Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen

Publications (1)

Publication Number Publication Date
PT826375E true PT826375E (pt) 2005-02-28

Family

ID=26028823

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97114330T PT826375E (pt) 1996-08-28 1997-08-20 Utilizacao de lipidos complexos como aditivos estabilizadores para preparacoes farmaceuticas de misturas de enzimas digestivas

Country Status (22)

Country Link
US (1) US5993806A (pt)
EP (1) EP0826375B1 (pt)
JP (1) JP4593697B2 (pt)
CN (1) CN1199694C (pt)
AR (1) AR008807A1 (pt)
AT (1) ATE284225T1 (pt)
AU (1) AU722151B2 (pt)
BR (1) BR9704554B1 (pt)
CA (1) CA2213151C (pt)
CZ (1) CZ295329B6 (pt)
DE (2) DE19724845A1 (pt)
DK (1) DK0826375T3 (pt)
EE (1) EE04179B1 (pt)
ES (1) ES2235206T3 (pt)
HK (1) HK1005224A1 (pt)
HU (1) HUP9701437A3 (pt)
NO (1) NO973940L (pt)
NZ (1) NZ328616A (pt)
PL (1) PL190140B1 (pt)
PT (1) PT826375E (pt)
SK (1) SK284639B6 (pt)
TR (1) TR199700872A3 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074689A (en) * 1998-03-10 2000-06-13 Immucell Corporation Colonic delivery of protein or peptide compositions
KR100367659B1 (ko) * 2000-05-08 2003-01-14 주식회사 바이넥스 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
US20040033220A1 (en) * 2000-11-02 2004-02-19 Marcus Hartmann Use of enzymes obtained from ciliates as medicaments for promoting digestion
US20030099626A1 (en) * 2001-11-20 2003-05-29 Health Education Corporation Nutrient absorption enhancing compositions and methods
AU2005227090B2 (en) * 2004-03-22 2010-12-09 Abbott Laboratories Gmbh Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
US7153504B2 (en) * 2004-07-30 2006-12-26 Can Technologies, Inc. Stabilized pancreas product
CA2616062A1 (en) * 2005-07-20 2007-01-25 James S. Brophy Modification of particle morphology to improve product functionality
AU2006274835B2 (en) 2005-07-29 2012-05-24 Abbott Laboratories Gmbh Processes for the manufacture of sterilized pancreatin powder
US11266607B2 (en) 2005-08-15 2022-03-08 AbbVie Pharmaceuticals GmbH Process for the manufacture and use of pancreatin micropellet cores
US9198871B2 (en) 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US10072256B2 (en) 2006-05-22 2018-09-11 Abbott Products Gmbh Process for separating and determining the viral load in a pancreatin sample
US20110183050A1 (en) * 2006-07-20 2011-07-28 Brophy James S Modification of particle morphology to improve product functionality
US8444967B2 (en) 2010-07-09 2013-05-21 Master Supplements, Inc. Treatment including prebiotic composition for use with probiotics
US20090130063A1 (en) * 2007-11-15 2009-05-21 Solvay Pharmaceuticals Gmbh Process for separating and determining the viral load in a pancreatin sample
CN102231988A (zh) * 2009-01-29 2011-11-02 诺尔玛克药物有限责任及股份两合公司 细菌脂肪酶药物制剂
DE102009006594A1 (de) 2009-01-29 2010-08-05 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutisches Präparat
SI2621476T1 (sl) 2010-10-01 2014-12-31 Aptalis Pharma Limited Gastrorezistentne obloĹľene pankrelipazne formulacije z nizko trdnostjo
ES2784227T3 (es) 2013-08-09 2020-09-23 Allergan Pharmaceuticals Int Ltd Composición de enzimas digestivos adecuada para la administración entérica
BR112016000658A2 (pt) * 2013-11-05 2018-03-20 Allergan Pharmaceuticals International Limited pancreatina de alta atividade, processo para a preparação de pancreatina de aa tendo atividade lipásica específica de pelo menos aproximadamente 120 usp iu/mg e método de tratamento de um paciente sujeito a uma condição patológica associada com a insuficiência enzimática pandreática
JP2014193909A (ja) * 2014-06-04 2014-10-09 Nordmark Arzneimittel Gmbh & Co Kg 医薬調製物
US20160120964A1 (en) * 2014-11-05 2016-05-05 George Shlieout Processes for producing compositions with improved safety profile having lipase activity and compositions suitable for pharmaceutical use
WO2016126970A1 (en) 2015-02-04 2016-08-11 Abbvie Inc. Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency
DE102015114862A1 (de) * 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase
DE102015114857A1 (de) 2015-09-04 2017-03-09 Nordmark Arzneimittel Gmbh & Co. Kg Getränk, enthaltend eine pharmazeutische Zusammensetzung

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956483A (en) * 1968-10-24 1976-05-11 Wilson Pharmaceutical & Chemical Corporation Preparing pancreatin
US3991180A (en) * 1972-03-06 1976-11-09 Rohm And Haas Company Stabilization of internally administered pancreatic lipase
DE2512746C3 (de) * 1975-03-22 1980-04-24 Kali-Chemie Pharma Gmbh, 3000 Hannover Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin
GB1603640A (en) * 1977-07-20 1981-11-25 Gist Brocades Nv Enzyme particles
JPS58148814A (ja) * 1982-03-01 1983-09-05 Fujimoto Seiyaku Kk 消化酵素軟カプセル剤
JPS59169491A (ja) * 1983-03-15 1984-09-25 Duskin Franchise Co Ltd 酵素の安定化法
JPH0229950A (ja) * 1988-07-18 1990-01-31 Nec Corp 光ディスク
JP2679852B2 (ja) * 1989-11-29 1997-11-19 株式会社サム研究所 経口及び局所投与用生物活性蛋白組成物
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations
BR9205526A (pt) * 1991-01-24 1994-04-19 Martek Corp Sociedade Norte Am Misturas de oleos microbianos e usos dos mesmos
DE4200002A1 (de) * 1992-01-02 1993-07-08 Rudolf V Dipl Chem Dr Noronha Reinigungstablette fuer die zahnprothesen
AU7656894A (en) * 1993-09-15 1995-04-03 Unilever Plc Skin care method and composition
JPH09125096A (ja) * 1995-10-30 1997-05-13 Koei Sangyo:Kk 液状天然油脂洗剤

Also Published As

Publication number Publication date
BR9704554A (pt) 1998-09-15
CZ218497A3 (cs) 1998-03-18
CN1174743A (zh) 1998-03-04
BR9704554B1 (pt) 2011-12-27
NO973940D0 (no) 1997-08-27
EP0826375A3 (de) 2002-08-14
TR199700872A2 (xx) 1999-04-21
PL321825A1 (en) 1998-03-02
TR199700872A3 (tr) 1999-04-21
HUP9701437A3 (en) 2001-03-28
EE9700249A (et) 1998-04-15
CA2213151C (en) 2008-04-01
JPH1077236A (ja) 1998-03-24
CN1199694C (zh) 2005-05-04
NO973940L (no) 1998-03-02
CA2213151A1 (en) 1998-02-28
PL190140B1 (pl) 2005-11-30
EP0826375A2 (de) 1998-03-04
SK284639B6 (sk) 2005-08-04
AU722151B2 (en) 2000-07-20
HUP9701437A2 (hu) 1998-03-30
SK115997A3 (en) 1998-07-08
HU9701437D0 (en) 1997-10-28
US5993806A (en) 1999-11-30
NZ328616A (en) 1999-01-28
EP0826375B1 (de) 2004-12-08
DK0826375T3 (da) 2005-01-24
DE59712108D1 (de) 2005-01-13
JP4593697B2 (ja) 2010-12-08
EE04179B1 (et) 2003-12-15
AR008807A1 (es) 2000-02-23
CZ295329B6 (cs) 2005-07-13
HK1005224A1 (en) 1998-12-31
DE19724845A1 (de) 1998-03-05
AU3530997A (en) 1998-03-05
ATE284225T1 (de) 2004-12-15
ES2235206T3 (es) 2005-07-01

Similar Documents

Publication Publication Date Title
PT826375E (pt) Utilizacao de lipidos complexos como aditivos estabilizadores para preparacoes farmaceuticas de misturas de enzimas digestivas
CU23048A3 (es) Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos
NO980126D0 (no) Plaster-formulering for perkantal administrering av fenantyl
EE200200211A (et) Bitsüklilised aminohapped kui farmatseutilised toimeained
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
NO20001219D0 (no) Blanding for medikament-administrasjon
PT998272E (pt) Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol
NO995134D0 (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
NO304982B1 (no) Fosfolipid, fosfatidyletanolamin, farmas°ytisk, nµrings eller kosmetisk blanding omfattende nevnte fosfolipid eller fosfatidyletanolamin
NO994757D0 (no) FramgangsmÕte for oral administrasjon av proteiner
NO986023D0 (no) Vannbaserte farmas÷ytiske preparater
NO994003L (no) Farmasoytisk blanding
NO20004391D0 (no) Duftforsterkende preparater for kosmetikkprodukter
BR9507643A (pt) Métodos de uso para catalisadores de decomposição de peroxinitrito composições farmacéuticas para os mesmos
NO981166L (no) Fremstilling av askorbylmonofosfater
PL342362A1 (en) Water-containing preparations of parasticides applicable onto skin
AR016694A1 (es) Procedimiento para la preparacion de derivados de acidos 8-metoxi-3-quinoloncarboxilicos y procedimiento de purificacion.
BR9800440A (pt) Preparação de preparações de sabor disfarçado de derivados de quinolona antibacterianamente ativos
NO982874D0 (no) Farmas°ytiske preparater med vitamin D-analoger
ATA159197A (de) Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
PL332282A1 (en) Application of proteins as factors against autoimmunological diseases
DZ2560A1 (fr) Préparations pharmaceutiques de cilansétrone stabilisées contre la racémisation.
DK1041966T3 (da) Farmaceutiske præparater omfattende zafirlukast
ATE262917T1 (de) Präparation umfassend thiolgruppen-haltige proteine